The board of directors of Hochdorf Holding Ltd, together with the senior management team, has reviewed the group’s direction and the positioning of its subsidiaries. The board has now agreed on its initial course of action. The company is to focus on its fast-growing Baby Care division and closely examine all strategic options for the future of its 51 % subsidiary Pharmalys.

The Dairy Ingredients division will divest its production plant in Germany and develop a new strategy. The company’s Cereals & Ingredients division is to be discontinued due to a lack of critical size and scalability. Some of its business activities will be integrated into Dairy Ingredients or divested. The measures will allow existing resources to be targeted more effectively. The necessary financing is currently being agreed with the company’s credit and financial partners.